Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Both Semaglutide and Tirzepatide are injectable medications used primarily to manage type 2 diabetes and assist with weight loss treatment
Slowing gastric emptying and reducing appetite Decreasing postprandial and fasting glucose, as well as serum triglycerides Pharmacokinetics Synthetic GLP-1 agonists are resistant to degradation by DPP-4 , giving them a longer half-life than endogenous GLP-1
[Article] [PubMed]117
That is why every step - from manufacturing to packaging to testing - happens right here in the USA
The drug is manufactured by Novo Nordisk and administered as a weekly injection under the skin using a prefilled, single-dose pen
Needle: 2527 gauge, 1625 mm for SC is standard
US$ 28.99
US$ 26.36
US$ 25.64
US$ 23.43
US$ 22.92
US$ 21.33
